| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.4 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |